EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Evidence for hippocampal globotriaosylceramide (Gb3) accumulation and spatial memory impairment in a mouse model of Fabry disease

Marco Salluzzo, Francesca Flotta, Cecilia Delprete, Violetta Lazzarotti, Francesco Formaggio, Beatrice Vignoli, Ludovica Campolongo, Gabriele Campana, Lucia Carboni, Marco Canossa, Vincenzo Donadio, Rocco Liguori und 2 weitere

Neurobiology of Disease · 2026

DOI: 10.1016/j.nbd.2026.107516 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurobiology of Disease, 2026. Verfasst von Marco Salluzzo und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Clinical Sciences (DIMEC), University of Bologna, Italy. Hauptthemen laut MEDLINE: Fabry Disease, Trihexosylceramides, Hippocampus, Memory Disorders. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fondazione del Monte di Bologna e Ravenna, Fondazione Cassa di Risparmio in Bologna, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fabry disease (FD) is an X-linked lysosomal storage disorder caused by pathogenic variants in the GLA gene that reduce α-galactosidase A activity and lead to progressive accumulation of globotriaosylceramide (Gb3) and related glycosphingolipids. In the human brain, Gb3 deposition is reported predominantly within the endothelium of small cerebral vessels and is associated with cerebrovascular dysfunction, seizures, cognitive impairment, and neuropsychiatric symptoms. In experimental animal models, its regional distribution, cellular localization, and relationship to cognitive dysfunction remain incompletely defined and appear to vary according to species, model, age, disease severity, and detection method. Here, using the α-galactosidase A hemizygous knockout mouse (α-Gal A -/0) and immunofluorescence, we performed a regional and cell-type-specific characterization of Gb3 immunoreactivity in the hippocampus and assessed hippocampal-dependent spatial learning and memory. Compared with wild-type controls (α-Gal A +/0), α-Gal A -/0 mice showed a marked increase in hippocampal Gb3 immunoreactivity, with deposits localized mainly to vascular endothelial cells and frequent signal within the capillary lumen. Neuronal Gb3 signal was detected in dentate gyrus hilar neurons with mossy cell-like morphology. Gb3 did not overlap with astrocytic (GFAP) or microglial (Iba1) markers, although astrocytic endfeet and activated microglia were often apposed to Gb3-positive vessels. In parallel, α-Gal A (-/0) mice displayed impaired Morris water maze acquisition and reduced spatial memory during the probe trial, without changes in swimming speed or distance. These data suggest that α-Gal A deficiency is associated with increased hippocampal Gb3 immunoreactivity, mainly in neurovascular compartments, and with measurable impairment in spatial memory.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fabry DiseaseTrihexosylceramidesHippocampusMemory DisordersSpatial MemoryAnimalsDisease Models, AnimalMice, KnockoutMaze Learningalpha-GalactosidaseMiceMice, Inbred C57BLMaleMicrogliaAstrocytesNeuronsGlial Fibrillary Acidic Protein

Stichwörter der Autor:innen

AstrocyteFabry diseaseGlobotriaosylceramide (Gb3)MicrogliaMorris water mazeNeuronSpatial memoryα-Gal A(-/0) mouse model

Substanzen

Trihexosylceramidesglobotriaosylceramidealpha-GalactosidaseGlial Fibrillary Acidic Protein

Autor:innen und Institutionen

  • Department of Medical and Clinical Sciences (DIMEC), University of Bologna, Italy.
  • Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Italy.
  • IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy; Department of Pharmacy and Biotechnology (FaBiT), University of Bologna, Italy.
  • Department of Pharmacy and Biotechnology (FaBiT), University of Bologna, Italy.
  • Institute of Neuroscience, National Research Council, Padova Section, 35131 Padova, Italy.
  • Department of Cellular, Computational and Integrative Biology - CIBIO, University of Trento, Povo, Italy.

Förderung

  • Fondazione del Monte di Bologna e Ravenna
  • Fondazione Cassa di Risparmio in Bologna
  • Ministero della Salute

Zitieren

APA

Salluzzo, M., Flotta, F., Delprete, C., Lazzarotti, V., Formaggio, F., Vignoli, B., Campolongo, L., Campana, G., Carboni, L., Canossa, M., Donadio, V., Liguori, R., Caprini, M., & Rimondini, R. (2026). Evidence for hippocampal globotriaosylceramide (Gb3) accumulation and spatial memory impairment in a mouse model of Fabry disease. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2026.107516

Vancouver

Salluzzo M, Flotta F, Delprete C, Lazzarotti V, Formaggio F, Vignoli B, et al. Evidence for hippocampal globotriaosylceramide (Gb3) accumulation and spatial memory impairment in a mouse model of Fabry disease. Neurobiology of Disease. 2026. doi:10.1016/j.nbd.2026.107516

BibTeX
@article{Salluzzo2026,
  author = {Salluzzo, Marco and Flotta, Francesca and Delprete, Cecilia and Lazzarotti, Violetta and Formaggio, Francesco and Vignoli, Beatrice and Campolongo, Ludovica and Campana, Gabriele and Carboni, Lucia and Canossa, Marco and Donadio, Vincenzo and Liguori, Rocco and Caprini, Marco and Rimondini, Roberto},
  title = {Evidence for hippocampal globotriaosylceramide (Gb3) accumulation and spatial memory impairment in a mouse model of Fabry disease},
  journal = {Neurobiology of Disease},
  year = {2026},
  doi = {10.1016/j.nbd.2026.107516}
}
Kostenlos starten →